BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23335378)

  • 1. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
    Verouti SN; Tsoupras AB; Alevizopoulou F; Demopoulos CA; Iatrou C
    Int J Artif Organs; 2013 Feb; 36(2):87-96. PubMed ID: 23335378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor levels and metabolism in Tangier disease: a case study.
    Kolovou V; Papakonstantinou VD; Stamatakis G; Verouti SN; Xanthopoulou MN; Kolovou G; Demopoulos CA
    Lipids Health Dis; 2012 Jul; 11():89. PubMed ID: 22769014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure.
    Detopoulou P; Nomikos T; Fragopoulou E; Antonopoulou S; Kotroyiannis I; Vassiliadou C; Panagiotakos DB; Chrysohoou C; Pitsavos C; Stefanadis C
    Clin Biochem; 2009 Jan; 42(1-2):44-9. PubMed ID: 18955040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymes.
    Vlachogianni IC; Nomikos T; Fragopoulou E; Stamatakis GM; Karantonis HC; Antonopoulou S; Demopoulos CA
    Cytokine; 2013 Aug; 63(2):97-104. PubMed ID: 23673285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial.
    Gavriil L; Detopoulou M; Petsini F; Antonopoulou S; Fragopoulou E
    Br J Nutr; 2019 May; 121(9):982-991. PubMed ID: 30940217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and 6-Week follow-up levels of PAF and activity of its metabolic enzymes in patients with heart failure and healthy volunteers--a pilot study.
    Detopoulou P; Fragopoulou E; Nomikos T; Antonopoulou S; Kotroyiannis I; Vassiliadou C; Panagiotakos DB; Chrysohoou C; Pitsavos C; Stefanadis C
    Angiology; 2013 Oct; 64(7):522-8. PubMed ID: 23000600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?
    Tsoupras AB; Chini M; Tsogas N; Fragopoulou E; Nomikos T; Lioni A; Mangafas N; Demopoulos CA; Antonopoulou S; Lazanas MC
    AIDS Res Hum Retroviruses; 2008 Aug; 24(8):1079-86. PubMed ID: 18620493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of diet with PAF and its metabolic enzymes in healthy volunteers.
    Detopoulou P; Fragopoulou E; Nomikos T; Yannakoulia M; Stamatakis G; Panagiotakos DB; Antonopoulou S
    Eur J Nutr; 2015 Feb; 54(1):25-34. PubMed ID: 24639073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions.
    Vlachogianni IC; Fragopoulou E; Stamatakis GM; Kostakis IK; Antonopoulou S
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):176-83. PubMed ID: 26358846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics.
    Detopoulou P; Nomikos T; Fragopoulou E; Stamatakis G; Panagiotakos DB; Antonopoulou S
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):43-9. PubMed ID: 22079887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
    Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
    Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism.
    Nasopoulou C; Tsoupras AB; Karantonis HC; Demopoulos CA; Zabetakis I
    Lipids Health Dis; 2011 Nov; 10():213. PubMed ID: 22087726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of platelet-activating factor synthesis in human endothelial cells by activation of the de novo pathway. Phorbol 12-myristate 13-acetate activates 1-alkyl-2-lyso-sn-glycero-3-phosphate:acetyl-CoA acetyltransferase and dithiothreitol-insensitive 1-alkyl-2-acetyl-sn-glycerol:CDP-choline cholinephosphotransferase.
    Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
    J Biol Chem; 1991 Nov; 266(32):21358-61. PubMed ID: 1657961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty.
    Goudevenos J; Tselepis AD; Vini MP; Michalis L; Tsoukatos DC; Elisaf M; Ninio E; Sideris DA
    Eur J Clin Invest; 2001 Jan; 31(1):15-23. PubMed ID: 11168434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.
    Tsoupras AB; Chini M; Tsogas N; Lioni A; Tsekes G; Demopoulos CA; Lazanas MC
    J Inflamm (Lond); 2011 Jul; 8():17. PubMed ID: 21736752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells.
    Xanthopoulou MN; Asimakopoulos D; Antonopoulou S; Demopoulos CA; Fragopoulou E
    Food Chem; 2014 Dec; 165():50-9. PubMed ID: 25038648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
    Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen.
    Chini M; Tsoupras AB; Mangafas N; Tsogas N; Papakonstantinou VD; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):766-75. PubMed ID: 22050695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyso-PAF:acetyl-CoA acetyltransferase and CDP-choline cholinephosphotransferase activities in the rabbit endometrium.
    Kudolo GB; Harper MJ
    J Lipid Mediat Cell Signal; 1995 Mar; 11(2):145-58. PubMed ID: 7780682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.